An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.
67/37 kDa laminin receptor
CTRP6
Laminin
Oral squamous cell carcinoma
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
01
05
2019
accepted:
26
06
2019
pubmed:
30
6
2019
medline:
10
3
2020
entrez:
30
6
2019
Statut:
ppublish
Résumé
C1q/tumor necrosis factor-related protein-6 (CTRP6), also known as CTRP6 is identified adiponectin paralog. Although recent studies have revealed that adiponectin has an inhibitory role in carcinogenesis, the role of CTRP6 in carcinogenesis remains unclear. In this study, we found that eukaryotic recombinant CTRP6 protein bound to the cell surface membrane of cultured oral squamous cell carcinoma cells by immunofluorescence staining. Screening of CTRP6 binding protein in expression library followed by co-immunoprecipitation assay revealed that CTRP6 bound to the precursor of laminin receptor. CTRP6 disturbed the binding of laminin to the laminin receptor. Interestingly, the eukaryotic recombinant CTRP6 protein significantly suppressed the proliferation and Matrigel invasion activity of oral squamous cell carcinoma SAS cells in a dose-dependent manner. Moreover, administration of CTRP6 significantly attenuated the growth of SAS cells in xenoplant mice model. Laminin and laminin receptor are known to be overexpressed and promote the tumor growth in OSCC. Combined together, the present findings suggest that CTRP6 could repress progression of oral squamous cell carcinoma cells, putatively through disrupting the laminin-laminin receptor axis.
Identifiants
pubmed: 31254244
doi: 10.1007/s11033-019-04947-9
pii: 10.1007/s11033-019-04947-9
doi:
Substances chimiques
ADIPOQ protein, human
0
Adipokines
0
Adiponectin
0
C1qTNF6 protein, human
0
CTRP6 protein, mouse
0
Receptors, Laminin
0
Collagen
9007-34-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4967-4973Subventions
Organisme : KAKEN
ID : 15K08361
Organisme : KAKEN
ID : 15K19051
Références
Shi X, Zhang TT, Hu WP, Ji QH (2017) Marital status and survival of patients with oral cavity squamous cell carcinoma: a population-based study. Oncotarget 8:28526–28543. https://doi.org/10.2174/1874210601206010126
doi: 10.2174/1874210601206010126
pubmed: 28415710
pmcid: 5438670
Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221–1225. https://doi.org/10.1038/sj.bjc.6603051
doi: 10.1038/sj.bjc.6603051
pubmed: 16570048
pmcid: 2361397
Scherer PE, Williams S, Fogliano M et al (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749. https://doi.org/10.1074/jbc.270.45.26746
doi: 10.1074/jbc.270.45.26746
pubmed: 7592907
Maeda K, Okubo K, Shimomura I et al (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286–289. https://doi.org/10.1006/bbrc.1996.0587
doi: 10.1006/bbrc.1996.0587
pubmed: 8619847
Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697–10703. https://doi.org/10.1074/jbc.271.18.10697
doi: 10.1074/jbc.271.18.10697
pubmed: 8631877
Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83. https://doi.org/10.1006/bbrc.1999.0255
doi: 10.1006/bbrc.1999.0255
pubmed: 10092513
Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24–30. https://doi.org/10.1016/j.cca.2007.01.026
doi: 10.1016/j.cca.2007.01.026
pubmed: 17343838
pmcid: 2755046
Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M (2007) Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40:115–120. https://doi.org/10.1007/s00795-007-0364-9
doi: 10.1007/s00795-007-0364-9
pubmed: 17874043
Parida S, Siddharth S, Sharma D (2019) Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci 20(10):2519. https://doi.org/10.3390/ijms20102519
doi: 10.3390/ijms20102519
pmcid: 6566909
Sugiyama M, Takahashi H, Hosono K et al (2009) Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34:339–344
pubmed: 19148467
Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M (2019) Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 92:121–135. https://doi.org/10.1016/j.metabol.2018.11.001
doi: 10.1016/j.metabol.2018.11.001
pubmed: 30445141
Takeuchi T, Liang SB, Matsuyoshi N et al (2002) Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 82:1023–1029
doi: 10.1097/01.LAB.0000025391.35798.F1
pubmed: 12177241
Jin Z, Cheng Y, Olaru A et al (2008) Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. Int J Cancer 123:2331–2336. https://doi.org/10.1002/ijc.23804
doi: 10.1002/ijc.23804
pubmed: 18729198
Schäffler A, Buechler C (2012) CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 23:194–204. https://doi.org/10.1016/j.tem.2011.12.003
doi: 10.1016/j.tem.2011.12.003
pubmed: 22261190
Seldin MM, Tan SY, Wong GW (2014) Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord 15:111–123. https://doi.org/10.1007/s11154-013-9255-7
doi: 10.1007/s11154-013-9255-7
pubmed: 23963681
pmcid: 3931758
Shapiro L, Scherer PE (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8:335–338
doi: 10.1016/S0960-9822(98)70133-2
pubmed: 9512423
Murayama MA, Kakuta S, Inoue A et al (2015) CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun 6:8483. https://doi.org/10.1038/ncomms9483
doi: 10.1038/ncomms9483
pubmed: 26404464
pmcid: 4598845
Lei H, Wu D, Wang JY et al (2015) C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Res Cardiol 110:35. https://doi.org/10.1007/s00395-015-0492-7
doi: 10.1007/s00395-015-0492-7
pubmed: 25962701
Fan RH, Zhu XM, Sun YW et al (2016) CTRP6 inhibits fibrogenesis in TGF-β1-stimulated human dermal fibroblasts. Biochem Biophys Res Commun 475:356–360. https://doi.org/10.1016/j.bbrc.2016.05.013
doi: 10.1016/j.bbrc.2016.05.013
pubmed: 27155158
Wang C, Gao C, Zhuang JL et al (2012) A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 138:2127–2136. https://doi.org/10.1007/s00432-012-1288-x
doi: 10.1007/s00432-012-1288-x
pubmed: 22864815
Wang L, Liu Z, Duan L et al (2015) C1q tumor necrosis factor-related protein 6 (CTRP6) inhibits the proliferation and migration of ovarian cancer cells. Chin J Cell Mol Immunol 31:1664–1668
Pesapane A, Ragno P, Selleri C, Montuori N (2017) Recent advances in the function of the 67 kDa laminin receptor and its targeting for personalized therapy in cancer. Curr Pharm Des. https://doi.org/10.2174/1381612823666170710125332
doi: 10.2174/1381612823666170710125332
pubmed: 28699539
Takeuchi T, Adachi Y, Nagayama T (2011) Expression of a secretory protein CTRP6, a C1qTNF family member, in hepatocellular carcinoma. Anal Cell Pathol 34:113–121. https://doi.org/10.3233/acp-2011-009
doi: 10.3233/acp-2011-009
Kawashima K, Saigo C, Kito Y et al (2019) CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model. Oncol Lett 17:4811–4818. https://doi.org/10.3892/ol.2019.10164
doi: 10.3892/ol.2019.10164
pubmed: 31186687
pmcid: 6507424
Takeuchi T, Misaki A, Liang SB et al (2000) Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J Neurochem 74:1489–1497
doi: 10.1046/j.1471-4159.2000.0741489.x
pubmed: 10737605
Takeuchi T, Adachi Y, Sonobe H et al (2006) A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene 25:7059–7069. https://doi.org/10.1038/sj.onc.1209688
doi: 10.1038/sj.onc.1209688
pubmed: 16715130
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
doi: 10.1073/pnas.76.9.4350
pubmed: 388439
Takeuchi T, Adachi Y, Nagayama T et al (2012) A WWOX-binding molecule, transmembrane protein 207, is related to the invasiveness of gastric signet-ring cell carcinoma. Carcinogenesis 33:548–554. https://doi.org/10.1093/carcin/bgs001
doi: 10.1093/carcin/bgs001
pubmed: 22226915
Martignone S, Ménard S, Bufalino R et al (1993) Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 85:398–402
doi: 10.1093/jnci/85.5.398
pubmed: 8433393
Pellegrini R, Martignone S, Tagliabue E et al (1995) Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Treat 35:195–199
doi: 10.1007/BF00668209
pubmed: 7647341
Satoh K, Narumi K, Isemura M et al (1992) Increased expression of the 67 kDa-laminin receptor gene in human small cell lung cancer. Biochem Biophys Res Commun 182:746–752
doi: 10.1016/0006-291X(92)91795-R
pubmed: 1310392
D’Errico A, Garbisa S, Liotta LA et al (1991) Augmentation of type IV collagenase, laminin receptor, and ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 4:239–246
pubmed: 1646457
Mafune K, Ravikumar TS, Wong JM et al (1990) Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Res 50:3888–3891
pubmed: 2141294
Campo E, Monteagudo C, Castronovo V et al (1992) Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Am J Pathol 141:1073–1083
pubmed: 1443045
pmcid: 1886667
DiGiacomo V, Meruelo D (2016) Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein. Biol Rev Camb Philos Soc 91:288–310. https://doi.org/10.1111/brv.12170
doi: 10.1111/brv.12170
pubmed: 25630983
Digiacomo V, Gando IA, Venticinque L et al (2015) The transition of the 37-Kda laminin receptor (Rpsa) to higher molecular weight species: sumoylation or artifact? Cell Mol Biol Lett 20:571–585. https://doi.org/10.1515/cmble-2015-0031
doi: 10.1515/cmble-2015-0031
pubmed: 26146125
pmcid: 5240582
Rao CN, Castronovo V, Schmitt MC et al (1989) Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry 28:7476–7486
doi: 10.1021/bi00444a047
pubmed: 2531008
Wewer UM, Liotta LA, Jaye M et al (1986) Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci USA 83:7137–7141
doi: 10.1073/pnas.83.19.7137
pubmed: 2429301
Glogowska A, Kunanuvat U, Stetefeld J et al (2013) C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells. J Pathol 231:466–479. https://doi.org/10.1002/path.4257
doi: 10.1002/path.4257
pubmed: 24014093
Klonisch T, Glogowska A, Thanasupawat T et al (2017) Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells. Br J Pharmacol 174:1025–1033. https://doi.org/10.1111/bph.13559
doi: 10.1111/bph.13559
pubmed: 27443788